ProPhase Labs Management
Management criteria checks 1/4
ProPhase Labs' CEO is Ted Karkus, appointed in Jun 2009, has a tenure of 15.58 years. total yearly compensation is $3.37M, comprised of 20% salary and 80% bonuses, including company stock and options. directly owns 13.47% of the company’s shares, worth $1.44M. The average tenure of the management team and the board of directors is 1 years and 15.6 years respectively.
Key information
Ted Karkus
Chief executive officer
US$3.4m
Total compensation
| CEO salary percentage | 20.0% |
| CEO tenure | 15.6yrs |
| CEO ownership | 13.5% |
| Management average tenure | 1yr |
| Board average tenure | 15.6yrs |
Recent management updates
Recent updates
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding
Nov 09
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks
Nov 09Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower
Jul 03Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?
Mar 04ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry
Jan 09ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate
Sep 21Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt
Aug 11We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease
Apr 07ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly
Jan 24ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential
Oct 13ProPhase Labs Q2 2022 Earnings Preview
Aug 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$26m |
| Mar 31 2024 | n/a | n/a | -US$24m |
| Dec 31 2023 | US$3m | US$675k | -US$17m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | n/a | n/a | US$7m |
| Dec 31 2022 | US$902k | US$675k | US$18m |
| Sep 30 2022 | n/a | n/a | US$31m |
| Jun 30 2022 | n/a | n/a | US$27m |
| Mar 31 2022 | n/a | n/a | US$18m |
| Dec 31 2021 | US$941k | US$590k | US$6m |
| Sep 30 2021 | n/a | n/a | -US$5m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$460k |
| Dec 31 2020 | US$445k | US$125k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$249k | US$125k | -US$3m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$2m | US$210k | -US$2m |
Compensation vs Market: Ted's total compensation ($USD3.37M) is above average for companies of similar size in the US market ($USD640.16K).
Compensation vs Earnings: Ted's compensation has increased whilst the company is unprofitable.
CEO
Ted Karkus (65 yo)
15.6yrs
Tenure
US$3,367,200
Compensation
Mr. Ted William Karkus has served as the Chief Executive Officer of ProPhase Labs, Inc. since June 2009. Mr. Karkus founded 2001 Forrester Financial LLC and served as its Managing Member. He is a Managemen...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 15.6yrs | US$3.37m | 13.47% $ 1.4m | |
| Executive VP & Chief Information Officer | 1yr | no data | no data | |
| Senior VP and Director of Sales & Marketing - Nebula Genomics | 2yrs | no data | no data | |
| President of Nebula Genomics | 1yr | no data | no data | |
| Corporate Controller | less than a year | no data | no data |
1.0yrs
Average Tenure
Experienced Management: PRPH's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 15.6yrs | US$3.37m | 13.47% $ 1.4m | |
| Independent Director | 15.6yrs | US$223.00k | 0.43% $ 46.5k | |
| Independent Director | 5.7yrs | US$223.00k | 0% $ 0 |
15.6yrs
Average Tenure
66yo
Average Age
Experienced Board: PRPH's board of directors are seasoned and experienced ( 15.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 22:37 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ProPhase Labs, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hunter Diamond | Diamond Equity Research LLC |